Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-03

Clinical Trial Update: Effect of Intraarticular Ozone, Prolotherapy or Dexmedetomidine in Pain Limitation in Knee Osteoarthritis [NA]

View source ↗

Summary

A completed clinical trial evaluating intraarticular ozone, prolotherapy, and dexmedetomidine for pain reduction in knee osteoarthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)
  • Dextrose prolotherapy (dextrose prolotherapy)
  • Intraarticular ozone therapy (ozone)

Snippet

Sponsor: Tanta University | Conditions: Intraarticular, Ozone | NA | Status: COMPLETED